আইসলণ্ড - আইসল্যান্ডীয় - LYFJASTOFNUN (Icelandic Medicines Agency)

medical valley invest ab - duloxetinum hýdróklóríð - magasýruþolið hart hylki - 30 mg

আইসলণ্ড - আইসল্যান্ডীয় - LYFJASTOFNUN (Icelandic Medicines Agency)

medical valley invest ab - duloxetinum hýdróklóríð - magasýruþolið hart hylki - 60 mg

ইউরোপীয় ইউনিয়ন - আইসল্যান্ডীয় - EMA (European Medicines Agency)

astrazeneca ab - roflumilast - lungnasjúkdómur, langvarandi hindrandi - lyf til veikindi öndunarvegi sjúkdómum, - daliresp er ætlað fyrir viðhald meðferð alvarlega langvinn veikindi í lungum (llt) (fev1 post-berkjuvíkkandi minna en 50% spáð) í tengslum við langvarandi bronkítis í fullorðinn sjúklinga með sögu um tíð tilvikum eins og bæta-á að berkjuvíkkandi meðferð.

ইউরোপীয় ইউনিয়ন - আইসল্যান্ডীয় - EMA (European Medicines Agency)

axunio pharma gmbh - pirfenidone - idiopathic lungvefi - Ónæmisbælandi lyf - pirfenidone aet is indicated in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (ipf).

ইউরোপীয় ইউনিয়ন - আইসল্যান্ডীয় - EMA (European Medicines Agency)

viatris limited - pirfenidone - idiopathic pulmonary fibrosis; lung diseases; respiratory tract diseases - Ónæmisbælandi lyf - pirfenidone viatris is indicated in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (ipf).

আইসলণ্ড - আইসল্যান্ডীয় - LYFJASTOFNUN (Icelandic Medicines Agency)

glaxosmithkline pharma a/s - ropinirolum hýdróklóríð - forðatafla - 2 mg

আইসলণ্ড - আইসল্যান্ডীয় - LYFJASTOFNUN (Icelandic Medicines Agency)

glaxosmithkline pharma a/s - ropinirolum hýdróklóríð - forðatafla - 4 mg

আইসলণ্ড - আইসল্যান্ডীয় - LYFJASTOFNUN (Icelandic Medicines Agency)

glaxosmithkline pharma a/s - ropinirolum hýdróklóríð - forðatafla - 8 mg

আইসলণ্ড - আইসল্যান্ডীয় - LYFJASTOFNUN (Icelandic Medicines Agency)

alvogen ehf. - ropinirolum hýdróklóríð - forðatafla - 2 mg

আইসলণ্ড - আইসল্যান্ডীয় - LYFJASTOFNUN (Icelandic Medicines Agency)

alvogen ehf. - ropinirolum hýdróklóríð - forðatafla - 4 mg